Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy

Overview of attention for article published in Journal of Hepatocellular Carcinoma, September 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

googleplus: 1 Google+ user

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Google+ Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma

Article in Cureus (July 2023)

Pharmacokinetic study comparing doxorubicin concentrations after chemoembolization or intravenous administration in dogs with naturally occurring nonresectable hepatic carcinoma

Article in Journal of Veterinary Internal Medicine (August 2022)

Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients

Article in World Journal of Surgical Oncology (August 2022)